Only 3 out of 5 heart failure patients see cardiologist at least once a year: Study
New Delhi: Only around three out of five heart failure patients see a cardiologist at least once a year, according to new research released on Sunday.
The study, published in the European Heart Journal, shows that patients who do see a cardiologist once a year are around 24 per cent less likely to die in the following year.
It also shows which patients could benefit from seeing a cardiologist once a year and which patients should be seen more often. The research suggests that if cardiologists did see heart failure patients at least once a year, one life could be saved for every 11–16 patients seen.
'In patients with heart failure, the heart is unable to normalise blood flow and pressure. Heart failure can't usually be cured, but with the right treatment, symptoms can often be controlled for many years. At the moment, depending on the patient and their condition, for example whether they have chronic or acute heart failure, they may or may not be seen by a cardiologist,' said Dr Guillaume Baudry from the Clinical Investigation Centre of Nancy University Hospital in France.
The study included all French patients living with heart failure in January 2020 who had been diagnosed in the previous five years -- 655,919 people in total.
These patients were found using French national medical administrative data. Researchers broke the group down according to whether they had been hospitalised with heart failure in the last year or the last five years, and whether or not they were taking diuretics as a treatment.
Diuretics help the body eliminate excess sodium through urine, which reduces the build-up of fluid in the body.
Among all groups of patients, researchers found that around two out of every five patients did not see a cardiologist over the course of a year.
Those who did see a cardiologist were less likely to die of any cause and less likely to be hospitalised with heart failure in the following year.
For patients who had been hospitalised in the last year, four appointments with a cardiologist were optimal. This reduced the risk from 34.3 per cent to 18.2 per cent, according to the study.
Dr Baudry said: 'Although there are inherent limitations in observational research, our findings highlight the potential value of specialist follow-up, even in patients who appear clinically stable. Patients should feel encouraged to ask for a cardiology review, particularly if they have recently been in hospital or they are taking diuretics.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New Indian Express
7 hours ago
- New Indian Express
More microplastics in glass bottles than in plastic bottles: Study
PARIS: Drinks including water, soda, beer and wine sold in glass bottles contain more microplastics than those in plastic bottles, according to a surprising study released by France's food safety agency Friday. Researchers have detected the tiny, mostly invisible pieces of plastic throughout the world, from in the air we breathe to the food we eat, as well as riddled throughout human bodies. There is still no direct evidence that this preponderance of plastic is harmful to human health, but a burgeoning field of research is aiming to measure its spread. Guillaume Duflos, research director at French food safety agency ANSES, told AFP the team sought to "investigate the quantity of microplastics in different types of drinks sold in France and examine the impact different containers can have". The researchers found an average of around 100 microplastic particles per litre in glass bottles of soft drinks, lemonade, iced tea and beer. That was five to 50 times higher than the rate detected in plastic bottles or metal cans. "We expected the opposite result," PhD student Iseline Chaib, who conducted the research, told AFP. "We then noticed that in the glass, the particles emerging from the samples were the same shape, colour and polymer composition -- so therefore the same plastic -- as the paint on the outside of the caps that seal the glass bottles," she said. The paint on the caps also had "tiny scratches, invisible to the naked eye, probably due to friction between the caps when there were stored," the agency said in a statement. This could then "release particles onto the surface of the caps", it added.
Hindustan Times
13 hours ago
- Hindustan Times
Artichokes, a beloved Mediterranean vegetable, are a true culinary gem
Artichokes, a beloved Mediterranean vegetable, are a true culinary gem. With tender hearts and meaty leaves, they offer a subtle, nutty flavour perfect for antipasti, dips, pasta, and gourmet salads. A staple in Italian, French, and Spanish cuisine, artichokes can be grilled, stuffed, steamed, or marinated — adding elegance and depth to even Indian dishes. Preparing and eating them may take effort, but it's a labour of love your taste buds will thank you for. Once you remove the leaves and the choke, you'll reach the prized heart — a delicious reward for your patience. Cutting artichokes can seem tricky at first, but with a little practice, it becomes much easier. Medicos and dieticians alike praise artichokes for their abundance of antioxidants, fiber, and essential nutrients. They are known to support digestive health, liver function, and heart wellness. Dr Poonam Tiwari, Head of the Department of Dietetics at RMLIMS, highlights, 'Artichoke helps to regulate cholesterol levels and, as it contains cynarine, it supports bile production. It's low in calories and high in vitamins. Artichokes are both a nutritious and delicious addition to a healthy diet. Don't overcook or fry it to retain its authentic flavours.' Due to their preference for a Mediterranean climate, artichokes aren't widely cultivated in India. However, they are occasionally grown on a small scale in cooler regions like parts of Himachal Pradesh and Uttarakhand. They can be spotted in gourmet stores, with prices reaching up to ₹4,000 per piece. Despite their limited availability, the increasing interest in global cuisines is paving the way for artichokes to become a more common sight on Indian tables. Mediterranean Artichoke & Quinoa Salad Chef Mohd Shavez Ahmad, faculty at IHM, shares his recipe for a popular salad: 'Combine cooked quinoa with chopped canned artichoke hearts, cherry tomatoes, cucumber, Kalamata olives, and fresh parsley. Toss with a light dressing made of olive oil, lemon juice, garlic, and a pinch of salt and pepper. This salad is packed with protein, fiber, and antioxidants, making it perfect for a nourishing, cool meal during hot days. It's easy to prepare and offers a delightful balance of flavours and textures.' For a refreshing summer option, Chef Shavez offers an easy raita recipe: 'Try a Chilled Artichoke & Cucumber Raita — a refreshing twist on a classic Indian side. Made using readily available canned or marinated artichoke hearts (found in gourmet stores or online), chopped cucumber, hung curd, mint, and a dash of roasted cumin powder, it's light, cooling, and perfect for hot summers. This fusion raita pairs beautifully with grilled dishes or can be enjoyed on its own as a healthy snack, blending global taste with local ease.' Artichoke & Watermelon Chaat Ranjan Thakur, Executive Chef at Fairfield Marriott, suggests a gourmet twist for summer snacking with Artichoke and Watermelon Chaat: 'Combine juicy watermelon cubes with chopped canned artichoke hearts, a sprinkle of chaat masala, lemon juice, black salt, and fresh mint. This fusion salad offers the familiar tang of Indian street-style chaat with the delicate, nutty flavour of artichokes — perfect for warm climate. It's quick to prepare, hydrating, and ideal for those looking for something tasty yet healthy and unique.'
Indian Express
14 hours ago
- Indian Express
Scientists say they may have found a way to extend human lifespan
For decades, scientists have been trying to find a way to extend human lifespan, and while studies have shown that select lab animals can live longer by eating less, they haven't conducted these studies on humans. A century-old study on lab rats has shown that mice who eat less often outlive their fed counterparts, but it can be almost impossible for most humans to follow a permanent diet. However, a new study by the School of Biological Sciences, University of East Anglia, claims that a combination of FDA-approved drugs that mimic the effects of dieting might be the answer to a longer life. The two drugs – Rapamycin and Metformin are known to extend the lifespan of mice as much as up to 30 per cent. Rapamycin, which was first found in the 1970s in bacteria living on the Easter Island soil, has been traditionally used as a powerful immunosuppressant to prevent organ-transplant rejection. The drug works by disabling a particular switch which is used to inform cells when a cell has an abundance of nutrients. As for Metformin, it is a synthetic compound that is found in French Lilac or Goat's Rue, which doctors prescribe to control sugar levels in type 2 diabetes. Since both of these drugs are used to sense the nutrient and energy levels in the human body, biologists wanted to see if the combination of these drugs could have the same effect as eating less. To know more about their effects, scientists say they examined thousands of existing studies and came across 167 studies that focused on eight vertebrate species, like fish and monkeys, which offered them a detailed insight into how these drugs affected animals. Out of three strategies that help with longevity, eating less, taking Rapamycin and consuming Metformin, scientists say the most dependable way to increase the lifespan is to eat less, irrespective of the animal's sex. They also noted that the second most effective strategy to increase lifespan was to take Rapamycin, while Metformin had no substantial effect. However, scientists did say that the effect of Rapamycin on animals wasn't consistent, as, in some cases, studies have shown that eating less or taking Rapamycin reduced an animal's lifespan. Another thing to note here is that most of these positive effects were on mice and rats, which have genes similar to humans but are not exactly the same. And since Rapamycin does come with some side effects, like reduced immunity, scientists are now trying to see if lower doses of the drug offer some advantages without the side effects. According to an ongoing Rapamycin trial on humans, it was noted that lower doses of the drug might help increase the lifespan. But, as of now, the trial is still in progress and will take a few years before the results are out.
